Cerebral palsy (CP) represents a group of neurological disorders that significantly affect an individual's ability to coordinate muscle movement and maintain balance. This condition arises early in life and cannot manifest in adulthood. Beyond the primary motor impairments, many individuals with CP also experience associated conditions, including intellectual disabilities, seizures, and difficulties with vision, hearing, and speech, as well as orthopedic complications such as spinal curvatures and joint issues. While CP is non-progressive, meaning its neurological impact does not worsen over time, aging can introduce new challenges and exacerbate difficulties for those affected.
Hyperbaric oxygen therapy (HBOT) has emerged as a supportive treatment for mitigating the impacts of cerebral palsy. By exposing individuals to higher levels of oxygen under increased atmospheric pressure, HBOT aims to rejuvenate or improve the condition of the affected brain areas, particularly the penumbra—the area surrounding the core of brain damage. This enhanced oxygenation process has demonstrated promise in several studies, with reported improvements in the symptoms and complications associated with CP. Through such treatment, there is potential for significant enhancements in quality of life and functional abilities for individuals living with cerebral palsy.